profit from every $100 of sales.
$0$100
Abrdn Healthcare Opportunities Fund
$19.42+1.09% today
+7.9% in 1 year
1-year low $16.351-year high $20.21
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2024.
0%20% a year
You pay $4.25 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Abrdn Healthcare Opportunities Fund sold, what it kept, and what it did with the cash.
Sales went from -$84.2 million in 2022 to -$114 million in 2025, with -$115 million of profit last year.
SalesProfit
Abrdn Healthcare Opportunities Fund handed back 100% of the cash it generated last year.
$88M
Free cash flow 2025$88M
Bought back its own shares–
Paid as dividends$88M
Abrdn Healthcare Opportunities Fund vs. similar companies
Abrdn Healthcare Opportunities Fund grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Abrdn Healthcare Opportunities Fund | 4.2× · Cheap | ||
 BlackRock | 34.1× · Expensive | ||
 Blackstone | 49.9× · Expensive | ||
 Investor | 8.5× · Cheap | ||
 Brookfield | 71.8× · Very expensive |
AI analysis
An AI analyst reads Abrdn Healthcare Opportunities Fund's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -84 | 55 | 191 | -114 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| -86 | 53 | 190 | -115 | |
| -2.09 | 1.28 | 4.58 | – | |
| – | – | – | – | |
| – | – | – | – | |
| 102.5% | 96.5% | 99.2% | 101.0% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,066 | 1,062 | 1,173 | 970 |
| Cash | 0 | 0 | – | – |
| Total debt | 225 | 225 | 225 | 225 |
| Total liabilities | 230 | 230 | 229 | 230 |
| 836 | 833 | 944 | 741 | |
| 41 | 41 | 41 | – | |
| – | – | – | – | |
| -10.3% | 6.3% | 20.1% | -15.5% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 56 | 56 | 78 | 88 | |
| – | – | – | – | |
| 56 | 56 | 78 | 88 | |
| Dividends paid | 56 | 56 | 78 | 88 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 4.2×
- –
- 0.02
- 1.0×
- 4.2×
- 10.3×
- –
- 9.7%
- 23.6%
- 12.0%
Profitability
- -66.9%
- -751.8%
- 99.2%
- -751.8%
- -11.8%
- 3.5%
- -14.5%
- -11.8%
- -11.8%
- –
Growth
- +249.5%
- +257.8%
- −99.5%
- +9.9%
- +0.0%
Financial health
- -2.0×
- 0.30
- 23.2%
- -8.9×
- 6.89
- 6.89
- 0.02
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 3%of 749
Top 3%of 872
Top 1%of 883
Top 24%of 931
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Jun 7, 2024 | 2.98 | – | – |
| Sep 29, 2023 | -0.21 | – | – |
| Mar 30, 2023 | 1.49 | – | – |
| Sep 29, 2022 | -2.98 | – | – |
| Mar 30, 2022 | 0.90 | – | – |
| Mar 31, 2020 | -0.61 | – | – |
| Sep 30, 2019 | -0.08 | – | – |
| Mar 31, 2019 | -0.92 | – | – |
12.0%of the share price, paid each year
On $1,000 invested$120a year at today's yield, before tax
+9.9%2020 to 2025
Raised2 yearsin a row, in our data
Paid per share, each year
$1.65 in 2015 → $2.16 in 2025
How safe it looks
41.3% of its profit
Room to growStretchedMore than it earns: 100.0%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
42No pass
Benjamin Graham
80Pass
Philip Fisher
50No pass
Peter Lynch
97Pass
Joel Greenblatt
35No pass
Charlie Munger
45No pass
Terry Smith
36No pass
Questions about Abrdn Healthcare Opportunities Fund
Is Abrdn Healthcare Opportunities Fund a good stock to buy?
A strong, very profitable business, and the price looks low. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Abrdn Healthcare Opportunities Fund AI analysis
What does Abrdn Healthcare Opportunities Fund do?
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It is in Asset Management.
Does Abrdn Healthcare Opportunities Fund pay a dividend?
Yes. At today's price the dividend is 12.0% a year, about 41% of its yearly profit. In 2025 it paid out $88.4 million in dividends.
Is Abrdn Healthcare Opportunities Fund stock halal?
Yes. Abrdn Healthcare Opportunities Fund passes our halal screen: its business is permitted and its debt is 28% of its market value, under the 30% limit. How we check
How has Abrdn Healthcare Opportunities Fund stock done over the past year?
Up 7.9% over the past twelve months, to $19.42. It traded between $16.35 and $20.21 and is 3.9% below its high.
Who are Abrdn Healthcare Opportunities Fund's competitors?
The largest listed companies in the same industry are BlackRock, Blackstone, Investor and Brookfield. The peers table on this page compares their profit, growth and price with Abrdn Healthcare Opportunities Fund's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.